Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies.
about
Mitochondrial glutathione: features, regulation and role in diseaseBiomarkers in Cardiology - Part 2: In Coronary Heart Disease, Valve Disease and Special SituationsComparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouseProposal of an in silico profiler for categorisation of repeat dose toxicity data of hair dyes.The regulatory mechanisms of myogenin expression in doxorubicin-treated rat cardiomyocytesCardiac toxicity of anticancer agents.Systems pharmacology modeling: an approach to improving drug safety.Heme Oxygenase-1/Carbon Monoxide System and Embryonic Stem Cell Differentiation and Maturation into Cardiomyocytes.The roles of neuregulin-1 in cardiac development, homeostasis, and disease.Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases.Targeting BNIP3 in inflammation-mediated heart failure: a novel concept in heart failure therapy.A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.Acute adriamycin-induced cardiotoxicity is exacerbated by angiotension IINeuregulin 1 improves complex 2-mediated mitochondrial respiration in skeletal muscle of healthy and diabetic mice.FGF-2 and FGF-16 protect isolated perfused mouse hearts from acute doxorubicin-induced contractile dysfunction.Cardioprotective effects of nicorandil, a mitochondrial potassium channel opener against doxorubicin-induced cardiotoxicity in rats.Cardiotoxic Effects of Short-Term Doxorubicin Administration: Involvement of Connexin 43 in Calcium Impairment.Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib.
P2860
Q27026521-52089BEC-8302-4A01-B12D-54794A8344E7Q28087152-9739A78F-EDE5-43E8-8EEE-B746B00EFDFDQ28487998-11AEE2FF-10AA-4F42-9F0E-03B5E9DF67B4Q30828343-751856E6-B169-48CF-8206-6C54004BCEDAQ36545773-C7260EC6-3CDD-4616-BB8D-293B53129FF8Q38091377-BB31E04E-8444-43A7-A647-422AB555FF50Q38153621-5492C409-4BED-475E-95B1-C3BF140B697FQ38383959-112B4570-DC56-44DA-929E-747E3FAB9F87Q38448410-EF917043-AB3F-4B79-B34D-0B99B7855051Q38637311-25B5F000-728E-4ED4-9D62-773AB9B4D46DQ39823505-76B540C2-F3D1-4CDE-9CB9-55E1C4F6AD5CQ41367937-9A5C1E70-67DD-42F5-A2FC-5995E94061E4Q41376836-5637CBB5-FFD7-41F2-902A-E6591FF25C77Q41824778-A0FEC791-1372-43EF-A233-E54764173C45Q43707999-3278E975-5776-49A3-BB47-8644E0501521Q43972291-77D9656E-8D4E-40DF-9B56-08B45628C1D2Q46206820-CEE416EE-A38A-4DA3-907C-098BF4DB8EDBQ50420344-6E2695A7-CEA1-4844-B81A-66EB30104E1FQ55222160-33947456-59DD-4F26-8EA0-1A9154B1CB4C
P2860
Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mitochondria death/survival si ...... anticancer-targeted therapies.
@en
Mitochondria death/survival si ...... anticancer-targeted therapies.
@nl
type
label
Mitochondria death/survival si ...... anticancer-targeted therapies.
@en
Mitochondria death/survival si ...... anticancer-targeted therapies.
@nl
prefLabel
Mitochondria death/survival si ...... anticancer-targeted therapies.
@en
Mitochondria death/survival si ...... anticancer-targeted therapies.
@nl
P2093
P2860
P356
P1476
Mitochondria death/survival si ...... anticancer-targeted therapies.
@en
P2093
Christopher Hurt
David Montaigne
Remi Neviere
P2860
P304
P356
10.1155/2012/951539
P577
2012-03-20T00:00:00Z